Related references
Note: Only part of the references are listed.Role of Intravitreal Inflammatory Cytokines and Angiogenic Factors in Proliferative Diabetic Retinopathy
Jinzi Zhou et al.
CURRENT EYE RESEARCH (2012)
Increased Prostaglandin E2 (PGE2) Levels in Proliferative Diabetic Retinopathy, and Correlation with VEGF and Inflammatory Cytokines
Scott D. Schoenberger et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy
Jose A. R. Filho et al.
ACTA OPHTHALMOLOGICA (2011)
Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman et al.
OPHTHALMOLOGY (2011)
Vascular Endothelial Growth Factor in the Circulation in Cancer Patients May Not Be a Relevant Biomarker
Tatjana M. H. Niers et al.
PLOS ONE (2011)
Immunological mechanisms in the pathogenesis of diahetic retinopathy
Anthony P. Adamis et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography
Erdal Cavusoglu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Serum inflammatory markers in diabetic retinopathy
AD Meleth et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients
H Kakizawa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
VEGF164(165) as the pathological isoform:: Differential leukocyte and endothelial responses through VEGFR1 and VEGFR2
T Usui et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade
PL Lip et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Diabetic retinopathy
RN Frank
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
CP Wilkinson et al.
OPHTHALMOLOGY (2003)
VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization
S Ishida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice
R Tamarat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tests of glycemia for the diagnosis of type 2 diabetes mellitus
RG Barr et al.
ANNALS OF INTERNAL MEDICINE (2002)
Defining the relationship between plasma glucose and HbA1c -: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial
CL Rohlfing et al.
DIABETES CARE (2002)
Regulation of vascular endothelial growth factor expression by advanced glycation end products
C Treins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition
N Chaturvedi et al.
DIABETIC MEDICINE (2001)
Endothelial dysfunction in diabetes
AS De Vriese et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy
P Hovind et al.
KIDNEY INTERNATIONAL (2000)
Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood
E Gunsilius et al.
ONCOLOGY (2000)
Share Paper
